This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (January 2025) |
Nizar A. Mullani (born October 22, 1942) is an American physicist and entrepreneur. Mullani's research and technological innovation has included pioneering work in positron emission tomography, vein imaging and dermoscopy. He was the Georg Charles de Hevesy Nuclear Pioneer Award recipient in 2023.[1]
Nizar Abdul Mullani | |
|---|---|
| Born | Nizar Abdul Mullani October 22, 1942 Dar es Salaam, Tanzania |
| Alma mater | Washington University |
| Occupation(s) | Physicist, entrepreneur |
| Spouse |
Linda Mullani
(m. 1996; died 2021) |
| Children | Ethan Mullani (b. 1984) |
Since 1998, Mullani has focused on entrepreneurial ventures, bringing several of his inventions to market under the Veinlite[2] and DermLite[3] brands.
Early life and education
editMullani was one of five children born to Indian parents in Dar es Salaam, Tanzania.
In 1963, Nizar Mullani immigrated to the United States, enrolling at Washington University in St. Louis, Missouri. He graduated with a Bachelor of Science in Physics.
Early career
editFollowing his studies, Mullani was appointed as a Research Assistant at the Biomedical Computer Lab of the Washington University School of Medicine (1969–1980) where he worked on the early PET camera models and imaging techniques.
From 1976 to 1980, Mullani held a Research Assistant position at the Mallinckrodt Institute of Radiology.
In 1980, Mullani was hired as an Assistant Professor and Director of PET instrumentation at the University of Texas Medical School, developing an advanced Time-of-Flight PET camera.[4] He also contributed toward the development of the Rubidium-82 generator[5] for use with imaging blood flow in the heart.
Business career
editPositron Corporation
editIn 1984, Mullani founded Positron Corporation. Positron designed and manufactured POSICAM Positron Emission Tomography (PET) Scanners for the imaging of cancer and heart disease.
TransLite LLC
editIn 1998, Mullani launched TransLite LLC and the Veinlite brand. Veinlite devices utilize transillumination technology to image veins in real time. There have been three clinical validation studies performed using Veinlite devices, demonstrating an improvement in venous access success rates (92.9% first-stick success rate, compared to 72% in Standard of Care)[6][7][8] in children and adults.
3Gen LLC
editIn 1999, Mullani founded 3Gen LLC. He designed the first DermLite product and subsequently served as director of research and development responsible for new products. DermLite products use polarized imaging to magnify deep into the epidermis layer skin, aiding in early detection[9] of skin cancer.
Innovations and designs
editMullani holds several U.S. patents and trademarks[10] related to positron emission tomography, dermoscopy and vein imaging.
Awards and recognition
editIn 2023, Mullani was named recipient of the 2023 SNMMI Georg Charles de Hevesy Nuclear Pioneer Award, which is given each year to an individual for outstanding contributions to the field of nuclear medicine.
References
edit- ^ George Charles de Hevesy Nuclear Pioneer Awardees
- ^ Veinlite vein access devices
- ^ DermLite dermoscopy products
- ^ Feasibility of Time-of-Flight Reconstruction in Positron Emission Tomography
- ^ Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced Rubidium-82
- ^ Efficacy of Veinlite PEDI in Pediatric Peripheral Intravenous Access: A Randomized Controlled Trial
- ^ Veinlite transillumination in the pediatric emergency department: a therapeutic interventional trial
- ^ Pen Torch Transillumination: Difficult Venipuncture Made Easy
- ^ Dermatoscopy Image Characteristics and Differences among Commonly Used Standard Dermatoscopes
- ^ Patents and trademarks
External links
editThis article needs additional or more specific categories. (November 2024) |